Bidirectional control of keratinocyte differentiation and proliferation by transcription factor FOXQ1

转录因子FOXQ1对角质形成细胞分化和增殖的双向控制

基本信息

  • 批准号:
    10717982
  • 负责人:
  • 金额:
    $ 51.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-01 至 2028-06-30
  • 项目状态:
    未结题

项目摘要

The skin forms the first barrier against physical, biological and chemical insults and is essential for prevention of dehydration. To maintain this function epidermal keratinocytes undergo differentiation. During differentiation, the gene expression programs in keratinocytes switch from maintenance of cell proliferation to terminal differentiation. Calcium gradient formed between the basal and upper epidermal layers is a major factor underlying induction of terminal differentiation in keratinocytes. In addition, skin homeostasis relies on well- orchestrated intercellular communications mediated by cytokines that are produced by keratinocytes and other skin resident cells. We have identified that transcription factor FOXQ1 (a member of the Forkhead Box family of proteins) utilizes a novel, rheostat-like mechanism of transcriptional regulation of keratinocyte differentiation. Thus, in presence of low extracellular calcium, FOXQ1 repressed genes associated with epidermal differentiation in normal human keratinocytes (NHKs) and immortalized human keratinocytes (HaCaT). On the contrary, in calcium-treated (i.e. differentiation-induced) NHK and HaCaT cells, FOXQ1 activated the same set of genes. Therefore, in Specific Aim 1, we will identify the mechanisms underlying transcriptional regulation by FOXQ1 of keratinocyte differentiation. In addition, we demonstrated that under normal conditions, depletion of FOXQ1 in cultured keratinocytes decreased whereas its overexpression increased cell proliferation. Moreover, Foxq1-/- mice demonstrated decreased epidermal hyperplasia in response to treatment with imiquimod which induces psoriasis-like phenotypes in mouse epidermis. Therefore, in Specific Aim 2, we will generate keratinocyte-specific Foxq1 knock-out mice and identify the mechanisms of FOXQ1 regulation by pro-inflammatory cytokines and the role of Foxq1 in regulation of keratinocyte hyper-proliferation.
皮肤是抵御物理、生物和化学侵害的第一道屏障,对预防至关重要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mikhail Nikiforov其他文献

Mikhail Nikiforov的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mikhail Nikiforov', 18)}}的其他基金

The role of regulation and subcellular localization of GTP biosynthesis in melanoma invasion and metastasis
GTP生物合成的调控和亚细胞定位在黑色素瘤侵袭和转移中的作用
  • 批准号:
    10636058
  • 财政年份:
    2023
  • 资助金额:
    $ 51.31万
  • 项目类别:
Regulation and Function of Very Long Chain Fatty Acid Biosynthesis in Multiple Myeloma
多发性骨髓瘤中极长链脂肪酸生物合成的调控和功能
  • 批准号:
    10560857
  • 财政年份:
    2022
  • 资助金额:
    $ 51.31万
  • 项目类别:
Regulation and Function of Very Long Chain Fatty Acid Biosynthesis in Multiple Myeloma
多发性骨髓瘤中极长链脂肪酸生物合成的调控和功能
  • 批准号:
    10441549
  • 财政年份:
    2022
  • 资助金额:
    $ 51.31万
  • 项目类别:
Regulation and Function of Very Long Chain Fatty Acid Biosynthesis in Multiple Myeloma
多发性骨髓瘤中极长链脂肪酸生物合成的调控和功能
  • 批准号:
    10317554
  • 财政年份:
    2021
  • 资助金额:
    $ 51.31万
  • 项目类别:
GMPS-GMPR axis melanoma progression and therapy
GMPS-GMPR轴黑色素瘤进展和治疗
  • 批准号:
    9920697
  • 财政年份:
    2018
  • 资助金额:
    $ 51.31万
  • 项目类别:
GMPS-GMPR Axis Melanoma Progression and Therapy
GMPS-GMPR 轴黑色素瘤进展和治疗
  • 批准号:
    10560855
  • 财政年份:
    2018
  • 资助金额:
    $ 51.31万
  • 项目类别:
Inhibition of MYC interactions with chromatin-remodeling factors as a novel anti-melanoma strategy
抑制 MYC 与染色质重塑因子的相互作用作为一种新型抗黑色素瘤策略
  • 批准号:
    9808913
  • 财政年份:
    2017
  • 资助金额:
    $ 51.31万
  • 项目类别:
Inhibition of MYC interactions with chromatin-remodeling factors as a novel anti-melanoma strategy
抑制 MYC 与染色质重塑因子的相互作用作为一种新型抗黑色素瘤策略
  • 批准号:
    9380591
  • 财政年份:
    2017
  • 资助金额:
    $ 51.31万
  • 项目类别:
KLF9-TXNRD2 axis in melanoma progression and metastasis
KLF9-TXNRD2 轴在黑色素瘤进展和转移中的作用
  • 批准号:
    9108882
  • 财政年份:
    2015
  • 资助金额:
    $ 51.31万
  • 项目类别:
KLF9-dependent pathways in multiple myeloma drug resistance
多发性骨髓瘤耐药中 KLF9 依赖性途径
  • 批准号:
    9806425
  • 财政年份:
    2015
  • 资助金额:
    $ 51.31万
  • 项目类别:

相似海外基金

Elucidation of atopic dermatitis pathology through nucleic acid-independent single-cell microbiome analysis
通过不依赖核酸的单细胞微生物组分析阐明特应性皮炎病理学
  • 批准号:
    23H02930
  • 财政年份:
    2023
  • 资助金额:
    $ 51.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of the mechanism related to dental metal allergy to exacerbation of atopic dermatitis
阐明牙科金属过敏与特应性皮炎恶化的相关机制
  • 批准号:
    23K16062
  • 财政年份:
    2023
  • 资助金额:
    $ 51.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Skin probiotics to treat atopic dermatitis
皮肤益生菌治疗特应性皮炎
  • 批准号:
    10760367
  • 财政年份:
    2023
  • 资助金额:
    $ 51.31万
  • 项目类别:
Investigation of Filaggrin Gene Mutations among Latinx patients with Atopic Dermatitis
拉丁裔特应性皮炎患者丝聚蛋白基因突变的调查
  • 批准号:
    10740811
  • 财政年份:
    2023
  • 资助金额:
    $ 51.31万
  • 项目类别:
Genetic analysis of the pathogenesis of atopic dermatitis focusing on the allergic sensitivity of NC mice.
以NC小鼠过敏敏感性为重点的特应性皮炎发病机制的遗传分析。
  • 批准号:
    23K05600
  • 财政年份:
    2023
  • 资助金额:
    $ 51.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clarification of the pathogenic mechanism of atopic dermatitis-associated brain inflammation
阐明特应性皮炎相关脑炎症的发病机制
  • 批准号:
    23KF0068
  • 财政年份:
    2023
  • 资助金额:
    $ 51.31万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Living systematic review and network meta-analysis of systemic immunomodulatory treatments for atopic dermatitis
特应性皮炎全身免疫调节治疗的活体系统评价和网络荟萃分析
  • 批准号:
    485092
  • 财政年份:
    2023
  • 资助金额:
    $ 51.31万
  • 项目类别:
    Operating Grants
Patient engagement in atopic dermatitis (eczema) guidelines and a model for future trustworthy, patient-centred guidelines
患者参与特应性皮炎(湿疹)指南以及未来值得信赖、以患者为中心的指南模型
  • 批准号:
    485111
  • 财政年份:
    2023
  • 资助金额:
    $ 51.31万
  • 项目类别:
    Operating Grants
Living systematic review and network meta-analysis of systemic immunomodulatory treatments for atopic dermatitis
特应性皮炎全身免疫调节治疗的活体系统评价和网络荟萃分析
  • 批准号:
    485106
  • 财政年份:
    2023
  • 资助金额:
    $ 51.31万
  • 项目类别:
    Operating Grants
Defining the role of IL-18 in atopic dermatitis
定义 IL-18 在特应性皮炎中的作用
  • 批准号:
    10681016
  • 财政年份:
    2023
  • 资助金额:
    $ 51.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了